4//SEC Filing
Wong Brian Russell 4
Accession 0001209191-19-055034
CIK 0001673772other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 6:57 PM ET
Size
9.2 KB
Accession
0001209191-19-055034
Insider Transaction Report
Form 4
Wong Brian Russell
DirectorPRESIDENT AND CEO
Transactions
- Conversion
Series B Preferred Stock
2019-11-04−150,000→ 0 total→ Common Stock (25,000 underlying) - Conversion
Common Stock
2019-11-04+25,000→ 355,000 total(indirect: By Trust) - Purchase
Common Stock
2019-11-04$12.00/sh+25,000$300,000→ 125,000 total
Footnotes (2)
- [F1]At the closing of the Issuer's initial public offering, each share of Series B Preferred Stock of the Issuer automatically converted into approximately 0.166 shares of the Issuer's common stock (on an adjusted basis, after giving effect to the 1-for-6 reverse stock split of the common stock effected by the Issuer on July 19, 2019) for no additional consideration. Shares of Series B Preferred Stock have no expiration date.
- [F2]The shares are held directly by The Wong Family Trust Dated February 4, 2008 for which the Reporting Person is a trustee.
Documents
Issuer
RAPT Therapeutics, Inc.
CIK 0001673772
Entity typeother
Related Parties
1- filerCIK 0001646110
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 6:57 PM ET
- Size
- 9.2 KB